Cardiac Rhythm & Diagnostics
Advanced cardiac monitoring and rhythm management devices
Company profile
Engineering the extraordinary in healthcare technology
Company profile
Medtronic is a global leader in healthcare technology, developing and manufacturing medical devices, therapies, and services that improve patient outcomes across a broad spectrum of medical conditions. Founded in 1949, the company has grown into one of the world's largest medical technology companies, serving healthcare professionals, patients, and health systems in over 150 countries. The company's extensive product portfolio spans multiple therapeutic areas including cardiovascular solutions (cardiac rhythm management, interventional cardiology, cardiac surgery), diabetes management technologies, neurological therapies (deep brain stimulation, pain management, spinal solutions), surgical innovations (surgical robotics, surgical stapling, energy devices, navigation and imaging), and patient monitoring systems. Medtronic's surgical robotics division includes advanced robotic-assisted surgical platforms and the Touch Surgery Ecosystem for surgical education and planning. Medtronic serves diverse customer segments including hospitals and health systems, ambulatory surgery centers, office-based labs, physicians, and direct-to-patient services. The company emphasizes innovation through its research programs, clinical evidence generation, and partnerships with healthcare providers. With a mission to alleviate pain, restore health, and extend life, Medtronic combines engineering expertise with clinical insights to address complex healthcare challenges. The company maintains a strong focus on regulatory compliance, reimbursement support, and comprehensive training and education programs for healthcare professionals through its Medtronic Academy and other educational initiatives.
Company description Medtronic official website
Mission. Alleviate pain, restore health, and extend life.
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas · Embedded · Hybrid · On Premise deployment with recorded integration context.
Recorded integration context: Cerner, EHR systems, Epic.
Company milestones
Expansion of surgical robotics portfolio, Touch Surgery Ecosystem development, digital health monitoring platforms, MRI-conditional device innovations
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Advanced cardiac monitoring and rhythm management devices
Integrated insulin delivery and glucose monitoring systems
Robotic-assisted surgery platform for multiple surgical specialties
Modular robotic-assisted surgery platform for multiple surgical specialties
Advanced neuromodulation and neurosurgical devices
AI-powered patient monitoring and acute care solutions
Comprehensive spinal and orthopedic surgical solutions
Advanced energy devices for surgical tissue management
AI-powered surgical navigation and imaging solutions for precision surgery
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Journal of medical economics · Dec 1, 2026
Estimands in Cardiovascular Device Trials: What Are They and Why Do They Matter?Structural heart : the journal of the Heart Team · Nov 1, 2026
Study on identifying a consistent metric for comparison of fatigue performance of superelastic Nickel Titanium across different geometries and loading conditions.Journal of the mechanical behavior of biomedical materials · Nov 1, 2026
The Surgeon, the Robot, and the Stapler: Comparison of Stapling Strategies During Robotic Lobectomy.Innovations (Philadelphia, Pa.) · Oct 17, 2026
Evolution of Tined Leadless Pacemaker Implantation: Patient Selection, Implant Volume, Center Characteristics, and Safety Trends.Heart rhythm · Oct 16, 2026
Transcarotid Access for Transcatheter Aortic Valve Replacement With the Evolut Self-Expanding Valve: Outcomes from a Real-World Registry.The Annals of thoracic surgery · Oct 16, 2026
Clinical validation
No linked records are currently available.
Regulatory
K253379 · 510k · Mar 26, 2026
Stealth AXiS Surgical System with Stealth AXiS Spine clinical applicationK253381 · 510k · Feb 12, 2026
Aurora EV ICD (DVEA3E4)P220012/S059 · Pma · Oct 28, 2025
Cobalt MRI ICD (DDPB3D1, DDPB3D4, DVPB3D1, DVPB3D4); Cobalt XT MRI ICD (DDPA2D1, DDPA2D4, DVPA2D1, DVPA2D4); Crome MRI IP980016/S939 · Pma · Oct 28, 2025
O-arm O2 Imaging SystemK240465 · 510k · Jun 21, 2024
LINQ II Insertable Cardiac MonitorK233562 · 510k · Dec 6, 2023
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Medtronic's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
A first-of-its-kind platform enables patients to improve seizure detection algorithms through smartphone feedback, bypassing the need for expert intervention and transforming passive monitoring into active collaboration.
Clinical AI · Oct 14, 2026
New prescription software brings algorithm-driven insulin optimization to the 85% of diabetes patients who don't use pumps, eliminating the physician approval bottleneck.
Clinical AI · Oct 1, 2026
The transcatheter valve therapy leader has tapped a GE HealthCare veteran to build a new digital product engineering group focused on AI-enabled structural heart technologies, signaling a strategic shift toward connected cardiac devices.
Healthcare Operations · Sep 27, 2026
New national coverage determination expands access to transcatheter aortic valve replacement before cardiac damage occurs, reshaping a $7 billion market while requiring evidence generation for asymptomatic population.
Policy & Regulation · Sep 12, 2026
Healthcare distribution leader confirms cybersecurity incident after ShinyHunters extortion group allegedly compromised employee credentials through voice phishing to access cloud data warehouses containing sensitive medical information.
Healthcare Operations · Aug 30, 2026
Medical device giant secures FDA clearance for computer vision application that monitors surgical instruments in real time, marking a strategic push into AI-powered surgical robotics.
Healthcare Operations · Jul 28, 2026
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.